Role of blood pressure dysregulation on kidney and mortality outcomes in COVID-19. Kidney, blood pressure and mortality in SARS-CoV-2 infection.
Chiara LanzaniMarco SimoniniTeresa ArcidiaconoElisabetta MessaggioRomina BucciPaolo BettiMonica AvinoGiulia MagniChiara MaggioniCaterina ContePatrizia Rovere QueriniFabio CiceriAntonella CastagnaGiuseppe VezzoliPaolo Manuntanull nullPublished in: Journal of nephrology (2021)
In patients hospitalized for COVID-19, hypertension and low blood pressure at presentation are important risk factors for AKI and mortality. Early reduction of antihypertensive therapy may improve outcomes in patients with SARS-CoV-2 infection.
Keyphrases
- blood pressure
- hypertensive patients
- coronavirus disease
- sars cov
- cardiovascular events
- heart rate
- respiratory syndrome coronavirus
- end stage renal disease
- risk factors
- newly diagnosed
- chronic kidney disease
- ejection fraction
- acute kidney injury
- type diabetes
- prognostic factors
- coronary artery disease
- bone marrow
- stem cells
- skeletal muscle
- metabolic syndrome
- cardiovascular disease
- insulin resistance
- glycemic control
- replacement therapy